Form 4 for TGTX TG THERAPEUTICS, INC.
Accepted 2024-01-05 00:00:00 ET · period of report 2024-01-03 · accession 0001437749-24-000756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-05 | 2024-01-03 | TGTX | Power Sean A | CFO | S - Sale | $16.91 | -47.9K | 607.0K | -7% | -$809.4K | |
| 2024-01-05 | 2024-01-05 | TGTX | Power Sean A | CFO | A - Grant | $0.00 | +75.0K | 682.0K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-03 | S | D | 47,867 | $16.91 | 606,969 | D | — | — | (F1) In connection with the vesting of 95,000 shares on January 1, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |
| 2 | Common | Common Stock | 2024-01-05 | A | A | 75,000 | $0.00 | 681,969 | D | — | — | (F3) Reflects a grant of restricted shares, of which 1/4 will vest on 1/1/2025, 1/4 will vest on 1/1/2026, 1/4 will vest on 1/1/2027, and 1/4 will vest on 1/1/2028. (F2) Includes shares of restricted Common Stock, which vest over various time periods. |